Company:  HOSPIRA INC (HSP)
Form Type:  10-Q
Filing Date:  11/7/2012 
CIK:  0001274057 
Address:  275 FIELD DR 
City, State, Zip:  LAKE FOREST, Illinois 60045 
Telephone:  (847) 937-6472 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$43.96  
Change: 
0.20 (0.46%)  
Trade Time: 
Apr 24  
Market Cap: 
$7.34B
Description of Business
Hospira, Inc. ("Hospira") is a provider of injectable pharmaceutical drugs and infusion technologies that it develops, manufactures, distributes and markets globally. Through a broad, integrated product portfolio, Hospira is uniquely positioned to Advance Wellness� by improving patient and caregiver safety while reducing healthcare costs. Hospira's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. Hospira's broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira was incorporated in Delaware on September 16, 2003, as a wholly owned subsidiary of Abbott Laboratories ("Abbott"). Hospira's business first began operation as part of Abbott in the 1930s.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements
        INCOME STATEMENT
        CASH FLOW
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        Notes to Condensed Consolidated Financial Statements
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use ...
      Item 6. Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 12.1
    RATIO COMPUTATION
  EXHIBIT 31.1
    Certification of Chief Executive Officer
  EXHIBIT 31.2
  EXHIBIT 32.1
    Certification of Chief Executive Officer Pursuant To
  EXHIBIT 32.2
    Certification of Chief Financial Officer Pursuant To
BROKERAGE PARTNERS